UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy Journal article
Yang, Guan-Jun, Wang, Wanhe, Mok, Simon Wing Fai, Wu, Chun, Law, Betty Yuen Kwan, Miao, Xiang-Min, Wu, Ke-Jia, Zhong, Hai-Jing, Wong, Chun-Yuen, Wong, Vincent Kam Wai, Ma, Dik-Lung, Leung, Chung-Hang. Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57(40), 13091-13095.
Authors:  Yang, Guan-Jun;  Wang, Wanhe;  Mok, Simon Wing Fai;  Wu, Chun;  Law, Betty Yuen Kwan; et al.
Favorite | TC[WOS]:122 TC[Scopus]:131  IF:16.1/16.2 | Submit date:2018/10/30
Drug Discovery  Epigenetics  Medicinal Chemistry  Triple-negative Breast Cancer  
An anti-prostate cancer benzofuran-conjugated iridium(III) complex as a dual inhibitor of STAT3 and NF-kappa B Journal article
Kang, Tian-Shu, Wang, Wanhe, Zhong, Hai-Jing, Dong, Zhen-Zhen, Huang, Qi, Mok, Simon Wing Fai, Leung, Chung-Hang, Wong, Vincent Kam Wai, Ma, Dik-Lung. An anti-prostate cancer benzofuran-conjugated iridium(III) complex as a dual inhibitor of STAT3 and NF-kappa B[J]. CANCER LETTERS, 2017, 396, 76-84.
Authors:  Kang, Tian-Shu;  Wang, Wanhe;  Zhong, Hai-Jing;  Dong, Zhen-Zhen;  Huang, Qi; et al.
Favorite | TC[WOS]:67 TC[Scopus]:67  IF:9.1/8.3 | Submit date:2018/10/30
Benzofuran-conjugated Iridium(Iii) Complex  Stat3  Nf-kappa b  Prostate Cells  Dual Inhibitors